Healthcare shares are mixed in pre-market trade.
Among the movers in the sector, shares of Ariad Pharmaceuticals
) were up 10% in recent Monday premarket action, continuing the
stock's climb after the European Medicines Agency's Committee for
Human Medicinal Products adopted a positive view Friday on the
continued use of the oncology company's Iclusig drug for patients
As the committee adopted the positive view Friday, it also made
a series of recommendations on measures to help minimize the risk
of occlusive vascular events. The recommendation means Iclusig can
continue to be used in its approved indications in the EU following
a review of updated safety data.
And, Clinical-stage biopharmaceutical company Dynavax
Technologies Corporation (
) is soaring about 6% after it was been upgraded by analysts at MLV
& Co. to a Buy rating from a Hold. The firm boosted the price
target on the stock more than four-fold to $5, from $1.50 a
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.